7H-Pyrimido[4,5-d]azepine-7-carboxylic acid, 2-cyclopropyl-3,4,5,6,8,9-hexahydro-4-oxo-, 1,1-dimethylethyl ester

7H-Pyrimido[4,5-d]azepine-7-carboxylic acid, 2-cyclopropyl-3,4,5,6,8,9-hexahydro-4-oxo-, 1,1-dimethylethyl ester Struktur
884487-26-7
CAS-Nr.
884487-26-7
Englisch Name:
7H-Pyrimido[4,5-d]azepine-7-carboxylic acid, 2-cyclopropyl-3,4,5,6,8,9-hexahydro-4-oxo-, 1,1-dimethylethyl ester
Synonyma:
tert-butyl 2-cyclopropyl-4-hydroxy-5,6,8,9-tetrahydro-7H-pyrimido[4,5-d]azepine-7-carboxylate;7H-Pyrimido[4,5-d]azepine-7-carboxylic acid, 2-cyclopropyl-3,4,5,6,8,9-hexahydro-4-oxo-, 1,1-dimethylethyl ester
CBNumber:
CB910415811
Summenformel:
C16H23N3O3
Molgewicht:
305.37
MOL-Datei:
884487-26-7.mol

7H-Pyrimido[4,5-d]azepine-7-carboxylic acid, 2-cyclopropyl-3,4,5,6,8,9-hexahydro-4-oxo-, 1,1-dimethylethyl ester Eigenschaften

Siedepunkt:
446.4±55.0 °C(Predicted)
Dichte
1.33±0.1 g/cm3(Predicted)
pka
1.97±0.20(Predicted)

Sicherheit

7H-Pyrimido[4,5-d]azepine-7-carboxylic acid, 2-cyclopropyl-3,4,5,6,8,9-hexahydro-4-oxo-, 1,1-dimethylethyl ester Chemische Eigenschaften,Einsatz,Produktion Methoden

7H-Pyrimido[4,5-d]azepine-7-carboxylic acid, 2-cyclopropyl-3,4,5,6,8,9-hexahydro-4-oxo-, 1,1-dimethylethyl ester Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


7H-Pyrimido[4,5-d]azepine-7-carboxylic acid, 2-cyclopropyl-3,4,5,6,8,9-hexahydro-4-oxo-, 1,1-dimethylethyl ester Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
BioPharmaMatrix,Inc. 0510-86010668
sales@biopharmamatrix.com China 4084 55
Shanghai Amico Chemicals Co. LTD 18019252918
sale@amkchem.com China 15001 58
Shanghai Easy CDMO Co.,Ltd 021-61734564
August@easycdmo.com China 10031 58

  • 7H-Pyrimido[4,5-d]azepine-7-carboxylic acid, 2-cyclopropyl-3,4,5,6,8,9-hexahydro-4-oxo-, 1,1-dimethylethyl ester
  • tert-butyl 2-cyclopropyl-4-hydroxy-5,6,8,9-tetrahydro-7H-pyrimido[4,5-d]azepine-7-carboxylate
  • 884487-26-7
Copyright 2019 © ChemicalBook. All rights reserved